ZymoGenetics

Home | Contact Us | Sitemap

  • Stock Quote
  • ZGEN:NASDAQ GM
  • Last: $5.12
  • Volume: 271,600
  • As of Feb 8, 2010 ET
  • Minimum 20 minutes delayed

ZymoGenetics Newsflash

ZymoGenetics will report Q4 and year end 2009 financial results on February 11 at 4:00 p.m. Eastern

THERAPEUTIC AREAS
  • Hepatitis C
    • PEG-Interferon lambda
  • Immunology
    • IL-31 mAb
  • Oncology
    • IL-21
  • Surgical Bleeding
NEWS
  • Feb 4, 2010 - ZymoGenetics to Host Conference Call and Webcast on February 11, 2010 to Discuss 2009 Year-end Financial Results
  • Feb 2, 2010 - New Publication Supports Safety Profile of RECOTHROM(R) Thrombin, Topical (Recombinant) in Numerous Surgical Settings
  • Jan 11, 2010 - ZymoGenetics Announces Full Exercise of Overallotment Option by Underwriters
  • News Archive »
EVENTS
  • Live Webcast
    Q4 2009 ZymoGenetics Inc. Earnings Conference Call
    February 11, 2010 at 4:30 p.m. ET
  • Replay
    ZymoGenetics and Bayer Restructure RECOTHROM® Agreements
    December 21, 2009 at 5:00 p.m. ET
  • Events Archive »
CORPORATE RESOURCES
  • 2008 Annual Report
  • Full Year 2008
  • 3rd Quarter 2009


© ZymoGenetics Inc., Terms & Conditions